Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Hyam, Elizabeth
DOB:	01-SEP-1942 (Age: 83)
Gender:	female
Address:	74 Preston Rd TQ9 3SB Moreleigh (United Kingdom)
ID:	6284-190445-1

Report
Date:	14-AUG-2024

Laboratory
dr Ample, Ex Boulevard du Jardin Botanique 32 1000 Brussels

Requested by
Totnes Community Hospital TQ9 5 Totnes (United Kingdom)

Specimen
Collected:	13-AUG-2024

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test	13 Aug 2024	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	5.4	4 - 6	%
Glucose [Mass/volume] in Blood	166.6 H	70 - 140	mg/dL
Urea nitrogen [Mass/volume] in Blood	14.7	7 - 25	mg/dL
Creatinine [Mass/volume] in Blood	0.5 L	0.6 - 1.1	mg/dL
Calcium [Mass/volume] in Blood	9.7	8.5 - 10.4	mg/dL
Sodium [Moles/volume] in Blood	142.1	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.7	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	109.8 H	98 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	23.5	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	257.0 H	130 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	244.4 H	50 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	168.5 H	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	39.6 L	50 - 60	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	2.0	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows persistently elevated fasting glucose and dyslipidemia (high total cholesterol, LDL, triglycerides, and low HDL) over three years, indicating increased cardiovascular risk. HbA1c remains within normal range, suggesting no established diabetes. Renal function is stable with low creatinine, and no significant proteinuria is present. Electrolytes are mostly normal, with mild hyperchloremia recently. Recommend further evaluation and management of metabolic syndrome and cardiovascular risk factors.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows persistently elevated fasting glucose and dyslipidemia (high total cholesterol, LDL, triglycerides, and low HDL) over three years, indicating increased cardiovascular risk. HbA1c remains within normal range, suggesting no established diabetes. Renal function is stable with low creatinine, and no significant proteinuria is present. Electrolytes are mostly normal, with mild hyperchloremia recently. Recommend further evaluation and management of metabolic syndrome and cardiovascular risk factors.